Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Eye drop recall overview:
- Who: Pharmedica USA has recalled its Purely Soothing 15% MSM Drops and Apotex Corp. has recalled its Brimonidine Tartrate Ophthalmic Solution.
- Why: The eyedrops are non-sterile and cracks have developed in the bottles of the ophthalmic solution.
- Where: The recalls are active in the United States.
Two more brands of eye drops have been recalled, after a national spate of eye drop recalls due to a lack of sterility.
On March 3, Pharmedica USA recalled its Purely Soothing 15% MSM Drops due to non-sterility. On March 2, Apotex Corp. recalled its Brimonidine Tartrate Ophthalmic Solution due to cracks that have developed in the bottles, also leading to non-sterility.
The recalls both come after the FDA recently expanded its eye drops and ointment recall and told consumers to stop using Delsam Pharma’s Artificial Eye Ointment due to a possible contamination with bacteria that has been linked to cases of blinding.
Pharmedica USA eye drop recall
According to the recall, Pharmedica USA LLC recalled two lots of its Purely Soothing, 15% MSM Drops sold at the consumer level.
“This product is being recalled due to non-sterility,” the company said. “Use of contaminated eye drops can result in the risk of eye infections that could result in blindness.”
To date, Pharmedica USA LLC has not received any reports of adverse events or illness related to the recalled product, it said.
The product was distributed worldwide by Purely Soothing LLC via online e-commerce and through trade shows. The affected eye drops are: Lot no. 2203PS01, 1 oz, UPC 7 31034 91379 9 and Lot no. 1808051, ½ oz, UPC 7 31034 91382 9.
Pharmedica is advising customers to immediately stop using the product and return it to the place of purchase.
Apotex Corp. eye drop recall
Meanwhile, Apotex Corp. recalled six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15% due to cracks that have developed in some of the bottles’ caps.
“There is a possibility the broken cap may impact sterility and if so, the possibility of adverse events,” the recall states.
The six recalled lots of Brimonidine Tartrate Ophthalmic Solution, 0.15% were distributed nationwide between April 05, 2022 and Feb. 22, 2023.
“Consumers with the impacted units of Brimonidine Tartrate Ophthalmic Solution, 0.15%, can contact Inmar Rx Solutions at 1-855-275-1273, to receive a recall/return packet including the Recall Stock Response Form,” the notice states.
If you or a loved one suffered from a bacterial infection, vision loss, other injury or death after using EzriCare eye drops, Delsam Eye Drops or Delsam eye ointment, you could join a lawsuit investigation.
Don’t Miss Out!
Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!
Read About More Class Action Lawsuits & Class Action Settlements:
- FDA expands recall of eye drops linked to bacterial contamination
- 1.2 million Walmart Mainstays candles recalled due to fire, laceration hazards
- Lidl recall announced for Tapas cocktail shrimp due to possible listeria contamination
- Platinum Health recalls adult bed rails due to entrapment, asphyxiation risks
4 thoughts onTwo more eye drops recalled due to lack of sterility
please add me
What do we do when the VA gives these eye drops to the Vets? Brimonidine Tartrate Ophthalmic Solution is a prescription drug for Glaucoma and is not an over-the-counter eye drop. Should the Vets contact an attorney or law firm for help or will the VA help the Vets as a whole?
I just purchased these eye drops, please add me.
Please add me.